Checkpoint inhibitor–induced rheumatic complications often arise lateMarch 15, 2021OncologyRheumatology
Nearly 20% of lupus patients have severe infection in first decade after diagnosisMarch 11, 2021RheumatologyInfectious Diseases
Bone loss common in kidney stone patients, yet rarely detectedMarch 10, 2021RheumatologyEndocrinologyNephrology
RECOVERY trial of COVID-19 treatments stops colchicine armMarch 8, 2021COVID-19 UpdatesRheumatologyInfectious DiseasesCardiology
Tocilizumab (Actemra) scores FDA approval for systemic sclerosis–associated interstitial lung diseaseMarch 5, 2021PulmonologyRheumatologyRare Diseases
ACR, AAD, AAO, RDS issue joint statement on safe use of hydroxychloroquineMarch 2, 2021DermatologyRheumatology
Rise of JAK inhibitors highlights axial spondyloarthritis year in reviewFebruary 25, 2021Rheumatology
COVID-19 vaccination recommended for rheumatology patientsFebruary 24, 2021COVID-19 UpdatesRheumatologyVaccines
Pandemic puts patients with psoriatic disease off seeking medical helpFebruary 23, 2021DermatologyRheumatologyCOVID-19 Updates
